Mutations in genes involved in DNA methylation (DNAme; for example, TET2 and DNMT3A)
are frequently observed in hematological malignancies 1 , 2 – 3 and clonal hematopoiesis 4 …

Pathogens have to balance transmission with persistence. For Plasmodium falciparum, the
most widespread and virulent malaria parasite, persistence within its human host requires …

Neoantigens arise from mutations in cancer cells and are important targets of T cell-mediated
anti-tumor immunity. Here, we report the first open-label, phase Ib clinical trial of a …

BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …

Background The ongoing COVID-19 pandemic has created an urgency to identify novel
vaccine targets for protective immunity against SARS-CoV-2. Early reports identify protective …

The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike …

BNT162b2, a lipid nanoparticle (LNP) formulated nucleoside-modified messenger RNA (mRNA)
encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike …

Neoantigens arising from mutations in tumor DNA provide targets for immune-based therapy.
Here, we report the clinical and immune data from a Phase Ib clinical trial of a personalized …

T cell responses play an important role in protection against beta-coronavirus infections,
including SARS-CoV-2, where they associate with decreased COVID-19 disease severity and …

Increasing evidence indicates CD4 + T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be presented …